State of Alaska Department of Revenue’s Amneal Pharmaceuticals AMRX Stock Holding History

State of Alaska Department of Revenue’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.29M	Sell	74,345 -27,064	-27%	-$371K	0.01%	913
2026 Q1	$1.26M	Buy	101,409 +83,797	+476%	+$1.13M	0.01%	961
2025 Q4	$221K	Buy	17,612 +542	+3%	+$6.2K	﹤0.01%	1650
2025 Q3	$170K	Buy	+17,070	New	+$153K	﹤0.01%	1611

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Westshore Wealth Newport Beach, California $322M AUM 24.46% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State of Alaska Department of Revenue's AMRX Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Amneal Pharmaceuticals (AMRX) stake by 27% in Q2 2026, selling an estimated $371K and leaving 74,345 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #913.

State of Alaska Department of Revenue first reported a position in AMRX in Q3 2025 and has held it in 4 quarters since. 189 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

State of Alaska Department of Revenue held 74,345 shares of Amneal Pharmaceuticals worth $1.29M as of Q2 2026.
State of Alaska Department of Revenue sold 27,064 Amneal Pharmaceuticals shares in Q2 2026, an estimated $371K.
Amneal Pharmaceuticals made up 0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #913 holding.
State of Alaska Department of Revenue first reported a position in Amneal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
189 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.